Serum 25-hydroxyvitamin D Concentration Significantly Decreases in Patients with COVID-19 Pneumonia During the First 48 Hours After Hospital Admission

Overview

Journal Nutrients

Date 2022 Jun 24

PMID 35745092

Authors

Juraj Smaha

Martin Kuzma

Peter Jackuliak

Samuel Nachtmann

Filip Max

Elena Tibenska

Neil Binkley

Juraj Payer

Affiliations

Soon will be listed here.

Abstract

It is unclear how ongoing inflammation in Coronavirus Disease 2019 (COVID-19) affects 25-hydroxyvitamin D (25[OH]D) concentration. The objective of our study was to examine serum 25(OH)D levels during COVID-19 pneumonia. Patients were admitted between 1 November and 31 December 2021. Blood samples were taken on admission (day 0) and every 24 h for the subsequent four days (day 1−4). On admission, 59% of patients were 25(OH)D sufficient (>30 ng/mL), and 41% had 25(OH)D inadequacy (<30 ng/mL). A significant fall in mean 25(OH)D concentration from admission to day 2 (first 48 h) was observed (30.7 ng/mL vs. 26.4 ng/mL; p < 0.0001). No subsequent significant change in 25(OH)D concentration was observed between day 2 and 3 (26.4 ng/mL vs. 25.9 ng/mL; p = 0.230) and day 3 and day 4 (25.8 ng/mL vs. 25.9 ng/mL; p = 0.703). The absolute 25(OH)D change between hospital admission and day 4 was 16% (4.8 ng/mL; p < 0.0001). On day 4, the number of patients with 25(OH)D inadequacy increased by 18% (p = 0.018). Therefore, serum 25(OH)D concentration after hospital admission in acutely ill COVID-19 patients should be interpreted with caution. Whether low 25(OH)D in COVID-19 reflects tissue level vitamin D deficiency or represents only a laboratory phenomenon remains to be elucidated in further prospective trials of vitamin D supplementation.

Citing Articles

Vitamin D, acute respiratory infections, and Covid-19: The curse of small-size randomised trials. A critical review with meta-analysis of randomised trials.

Autier P, Doi G, Mullie P, Vankrunkelsven P, DEcclesiis O, Gandini S PLoS One. 2025; 20(1):e0303316.

PMID: 39808630 PMC: 11731873. DOI: 10.1371/journal.pone.0303316.

Rise in Serum 25-Hydroxyvitamin D Levels during the COVID-19 Pandemic.

Durden W, Ezaldin S, Amos J, Kemper S, Campbell J Nutrients. 2024; 16(15).

PMID: 39125330 PMC: 11314379. DOI: 10.3390/nu16152449.

COVID-19 and Other Pleiotropic Actions of Vitamin D: Proceedings from the Fifth International Conference "Vitamin D-Minimum, Maximum, Optimum" under the Auspices of the European Vitamin D Association (EVIDAS).

Pludowski P Nutrients. 2023; 15(11).

PMID: 37299493 PMC: 10255692. DOI: 10.3390/nu15112530.

Vitamin D Deficiency Prevalence in Hospitalized Patients with COVID-19 Significantly Decreased during the Pandemic in Slovakia from 2020 to 2022 Which Was Associated with Decreasing Mortality.

Smaha J, Jackuliak P, Kuzma M, Max F, Binkley N, Payer J Nutrients. 2023; 15(5).

PMID: 36904131 PMC: 10005285. DOI: 10.3390/nu15051132.

Vitamin D and COVID-19: Narrative Review after 3 Years of Pandemic.

Gotelli E, Soldano S, Hysa E, Paolino S, Campitiello R, Pizzorni C Nutrients. 2022; 14(22).

PMID: 36432593 PMC: 9699333. DOI: 10.3390/nu14224907.

References

Bertoldo F, Pancheri S, Zenari S, Boldini S, Giovanazzi B, Zanatta M . Serum 25-hydroxyvitamin D levels modulate the acute-phase response associated with the first nitrogen-containing bisphosphonate infusion. J Bone Miner Res. 2010; 25(3):447-54. DOI: 10.1359/jbmr.090819. View

Lee P . Vitamin D metabolism and deficiency in critical illness. Best Pract Res Clin Endocrinol Metab. 2011; 25(5):769-81. DOI: 10.1016/j.beem.2011.03.001. View

Louw J, Werbeck A, Louw M, Kotze T, Cooper R, Labadarios D . Blood vitamin concentrations during the acute-phase response. Crit Care Med. 1992; 20(7):934-41. DOI: 10.1097/00003246-199207000-00007. View

Krishnan A, Ochola J, Mundy J, Jones M, Kruger P, Duncan E . Acute fluid shifts influence the assessment of serum vitamin D status in critically ill patients. Crit Care. 2010; 14(6):R216. PMC: 3219984. DOI: 10.1186/cc9341. View

Reid D, Toole B, Knox S, Talwar D, Harten J, OReilly D . The relation between acute changes in the systemic inflammatory response and plasma 25-hydroxyvitamin D concentrations after elective knee arthroplasty. Am J Clin Nutr. 2011; 93(5):1006-11. DOI: 10.3945/ajcn.110.008490. View

Erstad B . Albumin disposition in critically Ill patients. J Clin Pharm Ther. 2018; 43(5):746-751. DOI: 10.1111/jcpt.12742. View

Barth J, Field H, Mather A, Plein S . Serum 25 hydroxy-vitamin D does not exhibit an acute phase reaction after acute myocardial infarction. Ann Clin Biochem. 2012; 49(Pt 4):399-401. DOI: 10.1258/acb.2011.011195. View

Abrishami A, Dalili N, Torbati P, Asgari R, Arab-Ahmadi M, Behnam B . Possible association of vitamin D status with lung involvement and outcome in patients with COVID-19: a retrospective study. Eur J Nutr. 2020; 60(4):2249-2257. PMC: 7595877. DOI: 10.1007/s00394-020-02411-0. View

Wang Y, Dong C, Hu Y, Li C, Ren Q, Zhang X . Temporal Changes of CT Findings in 90 Patients with COVID-19 Pneumonia: A Longitudinal Study. Radiology. 2020; 296(2):E55-E64. PMC: 7233482. DOI: 10.1148/radiol.2020200843. View

10.

Newens K, Filteau S, Tomkins A . Plasma 25-hydroxyvitamin D does not vary over the course of a malarial infection. Trans R Soc Trop Med Hyg. 2005; 100(1):41-4. DOI: 10.1016/j.trstmh.2005.06.022. View

11.

Dhawan P, Christakos S . Novel regulation of 25-hydroxyvitamin D3 24-hydroxylase (24(OH)ase) transcription by glucocorticoids: cooperative effects of the glucocorticoid receptor, C/EBP beta, and the Vitamin D receptor in 24(OH)ase transcription. J Cell Biochem. 2010; 110(6):1314-23. DOI: 10.1002/jcb.22645. View

12.

Skversky A, Kumar J, Abramowitz M, Kaskel F, Melamed M . Association of glucocorticoid use and low 25-hydroxyvitamin D levels: results from the National Health and Nutrition Examination Survey (NHANES): 2001-2006. J Clin Endocrinol Metab. 2011; 96(12):3838-45. PMC: 3232615. DOI: 10.1210/jc.2011-1600. View

13.

Li X, Ma X . Acute respiratory failure in COVID-19: is it "typical" ARDS?. Crit Care. 2020; 24(1):198. PMC: 7202792. DOI: 10.1186/s13054-020-02911-9. View

14.

Kloc M, Ghobrial R, Lipinska-Opalka A, Wawrzyniak A, Zdanowski R, Kalicki B . Effects of vitamin D on macrophages and myeloid-derived suppressor cells (MDSCs) hyperinflammatory response in the lungs of COVID-19 patients. Cell Immunol. 2020; 360:104259. PMC: 7738277. DOI: 10.1016/j.cellimm.2020.104259. View

15.

DAvolio A, Avataneo V, Manca A, Cusato J, De Nicolo A, Lucchini R . 25-Hydroxyvitamin D Concentrations Are Lower in Patients with Positive PCR for SARS-CoV-2. Nutrients. 2020; 12(5). PMC: 7285131. DOI: 10.3390/nu12051359. View

16.

Campi I, Gennari L, Merlotti D, Mingiano C, Frosali A, Giovanelli L . Vitamin D and COVID-19 severity and related mortality: a prospective study in Italy. BMC Infect Dis. 2021; 21(1):566. PMC: 8200788. DOI: 10.1186/s12879-021-06281-7. View

17.

Smaha J, Kuzma M, Brazdilova K, Nachtmann S, Jankovsky M, Pastirova K . Patients with COVID-19 pneumonia with 25(OH)D levels lower than 12 ng/ml are at increased risk of death. Int J Infect Dis. 2022; 116:313-318. PMC: 8783398. DOI: 10.1016/j.ijid.2022.01.044. View

18.

Kurahashi I, Matsunuma A, Kawane T, Abe M, Horiuchi N . Dexamethasone enhances vitamin D-24-hydroxylase expression in osteoblastic (UMR-106) and renal (LLC-PK1) cells treated with 1alpha,25-dihydroxyvitamin D3. Endocrine. 2002; 17(2):109-18. DOI: 10.1385/ENDO:17:2:109. View

19.

Costa Silva M, Furlanetto T . Does serum 25-hydroxyvitamin D decrease during acute-phase response? A systematic review. Nutr Res. 2015; 35(2):91-6. DOI: 10.1016/j.nutres.2014.12.008. View

20.

Bang U, Novovic S, Moller Andersen A, Fenger M, Hansen M, Jensen J . Variations in serum 25-hydroxyvitamin D during acute pancreatitis: an exploratory longitudinal study. Endocr Res. 2011; 36(4):135-41. DOI: 10.3109/07435800.2011.554937. View